Form 4 for VNDA Vanda Pharmaceuticals Inc.
Accepted 2023-08-01 00:00:00 ET · period of report 2023-07-28 · accession 0001209191-23-043990 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-08-01 | 2023-07-28 | VNDA | Moran Kevin Patrick | SVP, CFO, Treas | S - Sale | $6.31 | -2,212 | 122.5K | -2% | -$14.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-28 | S | D | 1,800 | $6.31 | 120,714 | D | — | — | |
| 2 | Common | Common Stock | 2023-07-28 | S | D | 412 | $6.30 | 122,514 | D | — | — |